Systemic Sclerosis Interstitial Lung Disease: Early Diagnosis and Comprehensive Management

Interstitial lung disease (ILD) is a frequent complication of the autoimmune disorder systemic sclerosis (SSc). SSc-ILD remains a challenging condition to identify treat and manage. Early identification of ILD in patients with SSc is critical so that treatment can be initiated as soon as possible. However utilization of optimal screening and diagnosis strategies is low among healthcare providers. Treatment decisions also represent a significant clinical challenge a lack of guidance and effective treatments results in suboptimal practice and gaps in knowledge among providers. While new agents are on the horizon dissemination of clinical trial data and uptake of new agents may be delayed. Monitoring of SSc-ILD patients is equally difficult and research suggests suboptimal practice related to this aspect of care. Finally poor patient-provider communication amplifies these challenges and contributes to patient anxiety.

Share

Program Content

Activities

Systemic Sclerosis Interstitial Lung Disease
Systemic Sclerosis Interstitial Lung Disease: Early Diagnosis and Comprehensive Management
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: September 30, 2019

Expires: September 30, 2020

Activities

SSc-ILD Diagnosis and Management Summary
Systemic Sclerosis Interstitial Lung Disease: Summary
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 06, 2020

Expires: May 05, 2021

SSc-ILD Diagnosis and Management References
Systemic Sclerosis Interstitial Lung Disease: References
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 06, 2020

Expires: May 05, 2021

SSc-ILD FAQ
Systemic Sclerosis Interstitial Lung Disease: FAQs on Early Diagnosis and Comprehensive Management
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 21, 2020

Expires: May 20, 2021

Faculty

cover img faculity

Flavia Castelino, MD

Director, Scleroderma Program
Massachusetts General Hospital
Assistant Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Jane E. Dematte, MD, MBA

Professor of Medicine
Northwestern University
Feinberg School of Medicine
Director, Interstitial Lung Disease Program
Division of Pulmonary and Critical Care Medicine
Chicago, Illinois

Provided by

ProCE Banner

Supporters

This activity is supported by an independent educational grant from

Boehringer Ingelheim